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Abstract
Background: Strategies to improve the care of elderly, multimorbid patients frequently focus on implementing
evidence-based knowledge by structured assessments and standardization of care. In Germany, disease management
programs (DMPs), for example, are run by general practitioners (GPs) for this purpose. While the importance of such
measures is undeniable, there is a risk of ignoring other dimensions of care which are essential, especially for elderly
patients: their spiritual needs and personal resources, loneliness and social integration, and self-care (i.e., the ability of
patients to do something on their own except taking medications to increase their well-being). The aim of this study is
to explore whether combining DMPs with interventions to address these dimensions is feasible and has any impact on
relevant outcomes in elderly patients with polypharmacy.
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Methods: An explorative, cluster-randomized controlled trial with general practices as the unit of randomization will
be conducted and accompanied by a process evaluation. Patients aged 70 years or older with at least three chronic
conditions receiving at least three medications participating in at least one DMP will be included. The control group
will receive DMP as usual. In the intervention group, GPs will conduct a spiritual needs assessment during the routinely
planned DMP appointments and explore whether the patient has a need for more social contact or self-care. To
enable GPs to react to such needs, several aids will be provided by the study: a) training of GPs in spiritual needs
assessment and training of medical assistants in patient counseling regarding self-care and social activity; b) access to a
summary of regional social offers for seniors; and c) information leaflets on nonpharmacological interventions (e.g.,
home remedies) to be applied by patients themselves to reduce frequent symptoms in old age. The primary outcome
is health-related self-efficacy (using the Self-Efficacy for Managing Chronic Disease 6-Item Scale (SES-6G)). Secondary
outcomes are general self-efficacy (using the General Self-Efficacy Scale (GSES)), physical and mental health (using the
Short-Form Health Survey (SF-12)), patient activation (using the Patient Activation Measure (PAM)), medication
adherence (using the Medication Adherence Report Scale (MARS)), beliefs in medicine (using the Beliefs About
Medicines Questionnaire (BMQ)), satisfaction with GP care (using selected items of the European Project on Patient
Evaluation of General Practice (EUROPEP)), social contacts (using the 6-item Lubben Social Network Scale (LSNS-6)), and
loneliness (using the 11-item De-Jong-Gierveld Loneliness Scale (DJGS-11)). Interviews will be conducted to assess the
mechanisms, feasibility, and acceptability of the interventions.
Discussion: If the interventions prove to be effective and feasible, large-scale implementation should be sought and
evaluated by a confirmatory design.
Trial registration: German Clinical Trials Register (DRKS), DRKS00015696. Registered on 22 January 2019.
Keywords: Spiritual care, Primary care, Loneliness, Medication, Old age, Home remedies, Naturopathic medicine,
Alternative medicine, Self-efficacy, Self-care
Background
In most industrial countries the proportion of older people
in the general population is constantly increasing due to
lower birth rates and improved medical treatment options.
In Europe, the mean life expectancy is currently 83.1 years
for women and 77.5 years for men. About 20% of the Euro-
pean population is older than 65 years and this trend is ris-
ing since the fertility rate is 1.6 children per European
woman, lower than necessary to keep the population stable
[1]. Elderly people frequently suffer from multiple chronic
diseases and are consequently treated with polypharmacy.
Across Europe, 31% of older adults take five medications or
more per day [2]. Multimorbid patients with polypharmacy
have a higher risk for potentially avoidable hospitalizations
and adverse drug reactions causing a substantial proportion
of healthcare costs [3, 4]. Furthermore, they experience sig-
nificantly lower quality of life than those with single diseases
or taking fewer drugs [5].
Because of this, elderly patients with multimorbidity
and polypharmacy have been receiving increasing atten-
tion from healthcare research and health policies. Inter-
ventions to improve their care frequently focus on
medication safety, the prevention of delirium and falls,
or the maintenance of mobility and pain control. Com-
mon strategies to achieve these goals are the provision
of knowledge (e.g., by involving pharmacists into care),
comprehensive geriatric assessments, or disease and case
management [6, 7]. In Germany, disease management
programs (DMPs) for individuals with diabetes, coronary
heart disease and asthma/chronic obstructive pulmonary
disease (COPD) are run by general practitioners (GPs).
The core intervention of DMPs are regular appoint-
ments every 3–6 months during which a treatment
protocol has to be completed.
Although the value of implementing standards and
evidence-based knowledge into healthcare is undeniable,
there is a risk of focusing healthcare for elderly patients
too much on standardized measures overlooking other,
more individual dimensions of care which also influence
perceived quality of life. In a large German survey
among elderly patients, self-efficacy was the most im-
portant determinant for well-being [8]. Self-efficacy can
be defined as a person’s estimate of his or her own abil-
ity to succeed in reaching a specific goal, e.g., reducing
symptoms or maintaining good health. Consequently,
strengthening patients’ self-efficacy has the potential to
substantially improve their quality of life. Furthermore,
qualitative and quantitative research suggests that stron-
ger self-efficacy is associated with better medication ad-
herence [9–11].
As Fig. 1 shows, the intervention evaluated in this study
consists of three major components addressing three inter-
linked domains related to self-efficacy (spiritual needs, social
activity, and self-care) on which we will elaborate below.
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Spiritual needs
To be able to strengthen patients’ self-efficacy it is neces-
sary to be aware of their personal resources and their spir-
ituality. The conceptual definitions of spirituality vary
considerably [12]. In the context of healthcare, it is im-
portant to understand that spirituality is considered a di-
mension of the human being meaning that all humans
have spiritual needs which differ in form and content. For
this study, we define spiritual needs as everything which
gives meaning to a person’s life and thus serves as a per-
sonal resource.
A representative survey among Germans revealed that the
individual factors determining meaning of life change with
age. While younger persons mentioned “friends”, “partner-
ship”, or “work” as decisive factors, religious and nature ex-
periences were most important to patients aged 70 or older
[13]. A growing body of literature suggests connections be-
tween satisfaction of spiritual needs and mental and physical
health [14]. It has been substantiated for a broad spectrum
of conditions that a spiritual needs assessment reveals im-
portant information for the treatment of, for example,
schizophrenia [15], chronic kidney disease [16], diabetes
[17], or heart failure [18]. Several studies emphasize the role
of spiritual needs for medication adherence. A cross-
sectional study found that “spirituality, religiosity and per-
sonal beliefs were the only variables consistently associated
with compliance to medication” and suggested that “ad-
equately addressing these aspects on patient’s care may lead
to an improvement in adherence patterns” [18]. Another
cross-sectional study showed that adherent patients pre-
sented higher intrinsic religiosity [11]. Patients who were
less trusting that a “powerful other” will take care of them
were more likely to use unnecessary drugs [10]. An inter-
view study with 51 patients with hypertension concluded
that hopeless patients “adhere insufficiently or drop out
completely, only improving their adherence if something
happens that gives them hope or strength, or if they find a
medical team that provides enough emotional support” [9].
Research shows that the majority of patients have a
strong interest in discussing spirituality in medical en-
counters [19], and yet this aspect of care tends to be ig-
nored, except in some special fields such as palliative
care where spiritual care is being more and more imple-
mented. While 85% of primary care physicians think
they should be aware of patients’ spirituality, most would
not initiate a talk about it except for dying patients [20].
For many physicians, spirituality is an area that makes
them feel uncomfortable due to difficulties with spiritual
language and worries about time, ethical boundaries,
and reluctant reactions of the patient [14, 21, 22]. It has
been suggested that acquiring basic skills in spiritual
needs assessment should be part of medical training.
Fig. 1 Logic model of the HoPES3 program. BMQ Beliefs About Medicines Questionnaire, DJGS-11 11-Item De-Jong-Gierveld Loneliness Scale,
EUROPEP European Project on Patient Evaluation of General Practice, GP general practitioner, GSES General Self-Efficacy Scale, LSNS-6 6-Item
Lubben Social Network Scale, MA medical Assistant, MARS Medication Adherence Report Scale, PAM Patient Activation Measure, SES6G Self-
Efficacy for Managing Chronic Disease 6-Item Scale, SF-12 Short-Form Health Survey, SNQ Spiritual Needs Questionnaire
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Studies on spiritual care training for physicians draw
positive conclusions about the effectiveness and accept-
ance of the training by patients and physicians [23, 24]
and, in the United States, curriculums and objective
structured clinical examinations (OSCEs) for spiritual
care have already been established [25].
Loneliness/social activity
The perceived meaningfulness of life is strongly linked to
the degree to which a person maintains social relation-
ships [26]. In a survey among elderly people living in Ger-
man nursing homes, “feeling connected with family” was
the second most important spiritual need [27]. Lacking
self-efficacy, especially ‘spiritual health efficacy’ relating to
one’s perceived ability to generate spiritually based faith
and inner strength, proved to be a strong predictor for
loneliness in old age [28, 29]. ‘Social loneliness’, which re-
fers to the objective degree of social isolation or number
of social contacts, should be distinguished from emotional
loneliness, which refers to the subjective feeling of being
alone and which might also be the symptom of a psycho-
logical disease [30].
Unfortunately, many elderly people are not satisfied
with their social relationships. About one-fifth of the pa-
tients aged > 65 years in general practice feel often or oc-
casionally lonely and 55% of them would like to get
support to increase their social activity, but only 15% of
them ever talked to their GP about these issues [31, 32].
GPs rarely ask patients about loneliness and, if so, they do
it indirectly due to a feeling of powerlessness and inability
to provide adequate support [33]. However, several sys-
tematic reviews show that interventions to reduce loneli-
ness in elderly people can be effective [34–36]. Loneliness
in elderly people is a risk factor for increased disease bur-
den involving cognitive impairment [37], pain, depression,
and fatigue [38], and abuse of benzodiazepines [39]. Fur-
thermore, loneliness is associated with delayed hospital
stays and increased costs [40, 41]. However, not all elderly
patients suffer from being lonely. ‘Freedom’ and ‘inde-
pendence’ are positive dimensions attributed to loneliness
[42, 43]. For general practice it is important not to avoid
discussions about loneliness and to identify those patients
who need support to increase their social activity.
Self-care
In this project we define self-care activities as “activities
patients can perform on their own except taking medica-
tions to increase their well-being”. The positive correlation
between self-care and self-efficacy are well described, for
example, in studies among individuals with type 2 diabetes
[44]. Based on these studies, it may be summarized that
self-efficacy is a mediation variable for self-care behavior
associated with positive health outcomes [45]. This is also
expressed by the concept of ‘self-care self-efficacy’ which
is defined as “one’s perceived ability to perform relevant
self-care activities” and sometimes seen as a dimension of
self-management [45]. According to Buck et al., patient’s
confidence in their ability to perform self-care is a strong
predictor of physical and emotional quality of life [46].
A large number of health programs have been devel-
oped to improve patients’ self-care ability. These are
mostly disease-specific and often based on Orem’s nurs-
ing theory of self-care [45, 47–51]. This theory is based
on the assumption that people have a natural ability for
self-care, and nursing should focus on improving self-
care behavior. This aspect of self-efficacy is also consid-
ered by DMPs. As part of the DMPs, all patients should
participate in training sessions which focus on disease-
specific knowledge and skills (e.g., correct use of inhaler
devices for COPD, nutrition counseling for diabetes, and
so on) [52].
In this study we aim to advise patients about self-care
activities to enhance their self-care abilities for frequent
symptoms in old age which are not alarming for a severe
disease, e.g., knee pain in chronic osteoarthritis, chronic
sleeping disorders, and so on. The self-care activities will
focus on simple exercises (e.g., relaxation exercises, bal-
ance exercises) and on “home remedies”.
Home remedies or folk remedies are not clearly defined
and, as discussed by Parisius et al. [53], a scientific defin-
ition is lacking. They could be described as “a traditional
therapy often utilizing natural products, nutritional sup-
plements or physical measures. Its effectiveness may be
supported by familial, local or culturally accepted stories
or rituals” [54]. We decided to include home remedies as
an element in our intervention because they are easy to
adopt, and elderly people are generally used to home rem-
edies for self-care [55]. The application of home remedies
requires theoretical knowledge and practical skills and,
thus, optimally corresponds to the self-care concept. It is
hypothesized that the application of home remedies has a
positive effect on self-efficacy.
Objectives
The aim of this exploratory study and the accompanying
process evaluation is to assess the effectiveness and feasi-
bility of interventions to strengthen patients’ self-efficacy
by exploring their spiritual needs and personal resources
and by addressing loneliness and self-care if needed.
Methods/design
Trial design
Figure 2 illustrates the trial design. An open, exploratory,
cluster-randomized controlled trial with general practices
as the unit of randomization and a follow-up time of 6
months will be conducted.
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Study setting
The interventions will be implemented in GP practices in
the wider area around Heidelberg and Tübingen, two uni-
versity cities in the federal state of Baden-Württemberg in
southern Germany.
Eligibility criteria
Inclusion criterion for GPs is participation in at least one
DMP. Inclusion criteria for patients are: 1) age ≥ 70 years;
2) ≥ 3 chronic conditions defined by a previously pub-
lished diagnosis list [56]; 3) ≥ 3 medications on a long-
term basis; 4) participation in at least one DMP; and 5)
ability to give informed consent, to take part in the spirit-
ual needs assessment, and to complete the questionnaires
(if necessary with assistance by a person not involved in
the study) based on the GP’s personal assessment.
Interventions
Two types of interventions should be distinguished.
Interventions delivered by GPs and medical assistants to
patients
Patients in the intervention group will receive one pro-
longed counseling session as part of the regular appoint-
ment for the DMP during which their GP explores their
personal resources and spiritual needs, including the need
for more social contact and self-care activities. Based on
previous research, we assume that the spiritual needs as-
sessment will take 10–15min [23]. Trained medical assis-
tants will inform all patients about social activities for
seniors in the community and about nonpharmacological
treatment alternatives and, if appropriate, set targets with
the patients (another 10–15min). Patients in the interven-
tion group will receive a diary and be asked to document
when and how they conduct social or self-care activities.
Aids provided to the GP practices by the study
Patients, GPs, and medical assistants in the intervention
group will have access to a web portal developed by the
study team with a collection of social activities for seniors
in the region near the respective practice. Comprehensive
search options (radius search, thematic filters, map screens)
will facilitate the identification of suitable offers. Addition-
ally, the social activities will be made available as a brochure
in print form. Furthermore, information sheets developed
by the study team will be provided to the practices and pa-
tients in the intervention group in paper-based and digital
forms describing self-care activities (simple exercises and
home remedies) to reduce frequent symptoms in old age
which are not alarming for a severe disease. GPs and med-
ical assistants will participate in a 4- to 5-h workshop con-
ceptualized and led by the authors of this protocol. For
GPs, the workshop will comprise an introduction to the
definition of spirituality, the concept of spiritual care, and a
previously evaluated conversation technique (SPIR [23]), as
well as self-reflection of their own spirituality and practical
exercises on conducting a spiritual needs assessment based
on videos of real patients and role plays with trained actors.
The training of medical assistants will focus on patient
counseling regarding self-care and social activity and on the
handling of the web portal and the info sheets. Possible bar-
riers and facilitators for implementing the HoPES3 pro-
gram into practice will be discussed.
Control
In the control practices, DMPs will be conducted as usual.
Although DMPs are defined by a standardized treatment
form to be completed during each patient contact, the
way DMPs are organized in GP practices varies substan-
tially. To get a better idea of usual care in our study, we
will ask all participating GPs and medical assistants to de-
scribe how they usually organize DMPs in their practice.
Fig. 2 Trial design of the HoPES3 study. DMP disease management program
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Outcomes
The primary and secondary outcomes of this study will be
based on primary data collected in written, paper-based
surveys. The rationale for choosing the various outcomes
is shown schematically in Fig. 1. The primary outcome is
patients’ self-efficacy measured by the Self-Efficacy for
Managing Chronic Disease 6-Item Scale (SES6G). The
German version of the SES6G showed good construct val-
idity and high internal consistency [57]. In addition to
health-related self-efficacy, general self-efficacy will be
measured by the General Self-Efficacy Scale (GSES) [58].
Secondary outcomes were chosen to assess the ef-
fects of each of the single intervention components
and of the entire HoPES3 Program. To assess the pa-
tients’ social activity, the short, six-item version of the
Lubben Social Network Scale (LSNS-6) [59] and the
11-item De-Jong-Gierveld Loneliness Scale (DJGS-11)
[30] will be used. The LSNS-6 determines the number
of available contact persons (i.e., the degree of social
isolation) and the DJGS-11 measures the perceived so-
cial and emotional loneliness. Patients’ self-care abilities
will be estimated by the Patient Activation Measure
(PAM) [60]. Awareness of own spirituality or the pa-
tients’ spirituality, respectively, will be assessed by self-
developed items.
We hypothesize that the HoPES3 program will improve
patient quality of life as assessed by the Short Form Health
Survey (SF-12) [61], and satisfaction with GP care and
patient-centered communication will be assessed by se-
lected items of the European Project on Patient Evaluation
of General Practice (EUROPEP) questionnaire [62]. To ex-
plore whether HoPES3 has any influence on the use of
medications, the Medication Adherence Report Scale
(MARS) [11] and the general part of Beliefs About Medi-
cines Questionnaire (BMQ) [63] will be used. At the level
of GPs and medical assistants, work satisfaction (using the
Warr-Cook-Wall-Scale) [64], competence in providing
spiritual care (using the Spiritual Care Competence Ques-
tionnaire) [65], or in advising self-care activities and
awareness of own spirituality (using self-developed items)
will be assessed.
Other data
Besides outcome measures, descriptive data and process
data will be collected. We will use the Spiritual Needs
Questionnaire [66] and self-developed items to describe
the type and intensity of the spiritual needs of the sample
and whether their spirituality is a source of strength or ra-
ther a risk factor to them. Furthermore, we will collect
printouts of the diagnosis lists and medication lists saved
in the patient records of the participating practices. We
will ask GPs, medical assistants, and patients in the inter-
vention group to assess the usefulness of and strain caused
by the interventions within 2 weeks after the spiritual
needs assessment via a short self-developed questionnaire.
A diary will be given to patients in the intervention group
asking them to document how often and what type of so-
cial and self-care activities they apply. The log file of the
web portal will be analyzed to determine which functions
were used and how often.
After the intervention period terminates, interviews
with GPs, medical assistants, and patients in the inter-
vention group will be conducted, audiotaped, and tran-
scribed for the purpose of a comprehensive process
evaluation. Research questions of the process evalu-
ation are:
 Intervention fidelity
– Were the interventions delivered as specified in
the protocol?
– How is the acceptance of the interventions by
GPs, medical assistants, and patients?
– How feasible are the interventions for use in daily
practice?
– What are potential barriers and solutions for
delivering the interventions as intended?
 Intervention mechanisms
– What is the perceived benefit of the interventions
for patients and healthcare professionals? What
are potential harms?
– Which subgroups of patients profit from the
intervention, and which do not?
– How did the interventions influence the patient–
physician relationship?
– How did the interventions influence medical
treatment, especially medication adherence and
use of unnecessary drugs?
 Intervention costs
– How big is the effort for performing the
interventions?
Recruitment and participant timeline
The time schedule of the study is depicted in Fig. 3. GPs
offering DMPs will be recruited in the wider area of Hei-
delberg and Tübingen. For this purpose, the study infor-
mation will be sent to the practices of already established
research networks of the University Hospitals Heidelberg
and Tübingen. Participating GPs will identify all patients
meeting the eligibility criteria using the filter options of
their practice software. GPs will be asked to estimate
which patients would profit most from the HoPES3 pro-
gram and to include 15 of these patients into the study.
The reasons for selecting or excluding patients as well as
for refusing to participate will be documented and ex-
plored in the process evaluation. All participants will give
written informed consent. In case of patients, the informed
consent forms will remain in the practices.
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Management, collection, and monitoring of data
All data will be managed at the study center located at the
University Hospital Heidelberg, Department of General
Practice and Health Services Research. The study center
will receive patient data only in pseudonymized form and
will not have direct contact with patients (except for inter-
views with patients who gave their permission to be con-
tacted by the study team). Only authorized staff members
are able to enter or edit data. For specific research ques-
tions, parts of the data will be made available to partners of
the project (University Hospitals Munich and Tübingen) in
pseudonymous form after the trial biometrician has final-
ized the statistical report. The partners guarantee that
only the analyzing researchers will have access to the
data. It is also planned to make trial data on which
scientific publications are based and all the primary
data publicly available for re- and meta-analyses after
the trial has been completed.
A study nurse will monitor the data entry during the
entire study period. Furthermore, the study team will
Fig. 3 Time schedule of the HoPES3 study (following the SPIRIT recommendations). BMQ Beliefs About Medicines Questionnaire, DJGS-11 11-Item
De-Jong-Gierveld Loneliness Scale, EUROPEP European Project on Patient Evaluation of General Practice, GP general practitioner, GSES General
Self-Efficacy Scale, LSNS-6 6-Item Lubben Social Network Scale, MA medical Assistant, MARS Medication Adherence Report Scale, PAM Patient
Activation Measure, SES6G Self-Efficacy for Managing Chronic Disease 6-Item Scale, SCCQ Spiritual Care Competence Questionnaire, SF-12 Short-
Form Health Survey, WCWS Warr-Cook-Wall Scale
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visit all participating practices before randomization to
explain organizational issues related to the study. A Data
Safety and Monitoring Board (DSMB) consisting of a
GP, a statistician, and an expert in spiritual care will be
regularly informed about the course of the trial and all
safety issues, and asked for advice whether to continue,
modify, or stop the trial.
Sample size
The sample size was calculated using the primary end-
point, the SES6G at T1. With n = 22 practices (11 per
group) and n = 264 (132 per group) patients available for
analysis, it will be possible to detect a clinically relevant
mean difference of δ = 1 point at T1 between the two
treatment groups for the mean SES6G score at a two-
sided α of 0.05 with a power of 1 – β = 0.8, assuming a
standard deviation of σ = 2.2 based on the results of
Lorig et al. [67], a relatively high intraclass correlation
coefficient [68] of 0.05, and a cluster size of m = 12 (the
calculation was done using the function n4means from
the R package CRTSize). It is expected that, adjusting
for the SES6G score at T0, gender, age, number of co-
morbidities, and number of medications in the linear
mixed model used for statistical analysis will lead to less
unexplained variance and thus to an increase in power.
Taking drop-out rates of 7.5% at the practice level and
20% at the patient level, respectively, into account, n =
24 practices with n = 360 patients will be enrolled into
the trial. The potential problem of missing values for
drop outs will be partly resolved in the primary analysis
by application of the pre-defined imputation strategy.
Statistical methods
The primary objective of this study is to determine the ef-
fectiveness of a complex intervention compared with
usual care. The primary efficacy endpoint is the SES6G
score at T1. The study objective is statistically formulated
as a test of the null hypothesis H0: μI = μC (the mean
SES6G score at T1 in the intervention and the control
group are equal) against its alternative H1: μI ≠ μC at a sig-
nificance level of α = 0.05 (two-sided).
Because of the cluster randomization, the primary effi-
cacy analysis will use a multilevel regression approach with
patients at level one and practices at level two. The primary
efficacy analysis will be performed by fitting a linear mixed
model including the SES6G score at T1 as the dependent
variable, treatment group and gender as fixed factors, and
SES6G score at T0, age, number of comorbidities, and
number of medications as fixed covariates, and practice as
a random factor to account for the two-level data structure
(patients nested within practices). The results will be pre-
sented as the mean between-group difference in SES6G at
T1 with the corresponding 95% confidence interval. The
associated Cohen’s effect size d will be calculated. In
addition, the practice-related intracluster correlation coeffi-
cient (ICC) will be estimated. The primary analysis will be
performed adhering to the intention-to-treat principle. An
additional sensitivity analysis will be conducted on the per-
protocol analysis set. Missing data for the primary outcome
variable will be replaced using multiple imputation [69]
which takes the covariates of treatment group, gender, age,
number of comorbidities, number of medications, and
practice into account by application of the fully conditional
specification method [70]. Sensitivity analyses will be per-
formed by applying alternative methods dealing with miss-
ing data such as, for example, complete case analysis and
best/worst case imputation.
The statistical analyses of the secondary endpoints will
use the same multilevel approach as the primary ana-
lysis. All statistical tests will be two-sided at the signifi-
cance level of α = 0.05. Because no adjustments for
multiple endpoints are planned, findings will be inter-
preted with caution in view of the number of statistical
tests undertaken. Only the result of the primary efficacy
analysis will be interpreted in a confirmatory manner.
Confirmatory subgroup analyses are not planned. No in-
terim analysis with regard to efficacy will be done. All
analyses will be performed using SAS version 9.4 or
higher.
Assignment of interventions
As Fig. 2 shows, 360 patients and 24 practices will be re-
cruited (half in the area of Heidelberg, half in the area of
Tübingen) and randomized to either intervention or control
group using block randomization stratified by region (Hei-
delberg/Tübingen) to ensure an equal number of interven-
tion and control practices per region. The randomization
list will be created by the trial statistician. Since the inter-
vention involves training of GPs and informed consent of
patients, blinding of participants is not possible. However,
acknowledged measures to reduce bias such as computer-
ized randomization and blinding of outcome assessment
will be undertaken.
Harms
The pharmacological treatment of the patients is not al-
tered by the study, and therefore we do not expect severe
risks to health. However, it is possible that the spiritual
needs assessment causes psychological strain for the par-
ticipating patients and/or GPs. Although the strain caused
by the conversation technique (SPIR) that will be applied
in this study was considered low in previous studies, we
will ask patients and GPs to evaluate the strain within 2
weeks after each assessment by means of a questionnaire.
The responses of each patient and those aggregated at a
practice level will be discussed with the DSMB.
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Discussion
To our knowledge, HoPES3 is the first study examining
interventions to address spiritual needs, social activity,
and self-care in elderly patients in German general
practice.
Since little is known about the effectiveness of such in-
terventions, HoPES3 is designed as an explorative trial.
This means we have chosen a range of secondary out-
comes beside the primary outcome to assess the possible
effects of the program. If the program proves to be ef-
fective and feasible, large-scale implementation should
be sought and evaluated by confirmatory research. This
could be done, for instance, by integrating the training
concept into the university curricula for medical stu-
dents or into continuous education of GPs or by collab-
orating with health insurance companies or local state
authorities.
In German language the term spirituality is frequently
associated with esotericism or religion. We are aware
that some GPs and maybe also patients might have a
negative attitude towards this topic. Therefore, we will
explain in the invitation letter and study information
how spirituality is defined in our project and that a spir-
itual needs assessment is a way of resource-oriented
communication which has the potential to reveal im-
portant information for the treatment of the patient.
However, we cannot exclude that there will be a selec-
tion bias in favor of those GPs and patients who are
already interested in the topic and assess this aspect dur-
ing the baseline assessment.
In this study, GPs will select those patients who, in their
opinion, will profit most from the intervention. While this
approach may be criticized in clinical research and efficacy
trials because it limits the generalizability of the findings,
it is justifiable in health services research which focusses
on the effectiveness of interventions under real-life condi-
tions. It is common in general practice that GPs decide
which treatment or which conversation technique is ap-
propriate for which patient. Therefore, we believe that the
selection of patients by GPs is a realistic approach which
would also be applied in case the HoPES3 program is im-
plemented into routine care. The reasons for selecting or
excluding patients will be examined and will reveal im-
portant information for the adaption and dissemination of
the program.
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